Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

Study summary

The objective of the pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth population health management program. The primary aims are to study the intervention and determine its effectiveness on telehealth engagement, clinical quality, and healthcare cost outcomes across personal characteristics.

Ask AI to explain this study

Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedNational TeleOncology

The study team can explain what participation involves.

Who it may be forLung Cancer Diagnosis · Colorectal Cancer (Diagnosis)

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jun 3, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?5 U.S. locations

Locations may change over time.

Who runs it?NYU Langone Health

Study sponsor

Study overview

What this study is about

Purpose: Health Services Research
Study type: Interventional
Phase: Not applicable
Sponsor: NYU Langone Health
Interventions being studied: Behavioral: National TeleOncology

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Supportive or behavioral care→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Patients 1. A Veteran 2. Aged 18 years or older 3. Newly diagnosed with lung, prostate, breast, or colon cancer within 3 months of telemedicine visit 4. Engaged in an oncology visit during the 36-month analysis period at a Veterans Affairs Medical Center (VAMC) location. VAMC Providers and Staff Inclusion Criteria: 1. Provider or staff member at one of the VAMC locations including physicians, nurse practitioners, physicians' assistants, and nurses caring for Veterans 2. Providers or staff members having helped provide care for at least 5 Veterans with cancer in the previous 6 months at a VAMC location Patients

Reasons someone may not be able to joinExclusion criteria

1. Veterans who have not seen any providers in the VA within the past year 2. Patients previously diagnosed with lung, prostate, breast, or colon cancer 3. Pregnant patients VAMC Providers and Staff

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

VA New York Harbor Healthcare System - BrooklynBrooklyn, New York
VA New York Harbor Healthcare System - St. Albans Community Living CenterJamaica, New York
VA New York Harbor Health Care System - ManhattanNew York, New York
VA New York Harbor Healthcare System - Harlem Community CenterNew York, New York
VA New York Harbor Healthcare System - Staten Island Community ClinicStaten Island, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 3, 2026. Always confirm current availability with the study team.

View original record ↗